RELMADA THERAPEUTICS, INC. | Business Contracts

Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on May 25, 2023)

Advisory Agreement dated as of January 1, 2023, between Relmada Therapeutics, Inc., and Paul Kelly (Filed With SEC on January 5, 2023)

Amendment No. 2 dated December 27, 2022, to the License Agreement originally dated January 16, 2018, as heretofore amended, between Relmada Therapeutics, Inc., and Dr. Charles E.... (Filed With SEC on December 28, 2022)

Form of Exchange Warrant (Filed With SEC on September 22, 2022)

Exchange Agreement between Relmada Therapeutics, Inc., and Venrock Healthcare Capital Partners EG, L.P., Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings... (Filed With SEC on September 22, 2022)

Relmada Therapeutics, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on June 1, 2022)

Underwriting Agreement, dated December 8, 2021, by and among Relmada Therapeutics, Inc. and Goldman Sachs & Co. LLC and Jefferies LLC, as representatives of the several... (Filed With SEC on December 13, 2021)

License Agreement dated as of July 16, 2021, between Arbormentis, LLC and Relmada Therapeutics, Inc (Filed With SEC on August 10, 2021)

Relmada Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on May 20, 2021)

Relmada Therapeutics, Inc., 2021 Equity Incentive Plan (Filed With SEC on March 24, 2021)

Severance and Separation Agreement, dated April 1, 2020, by and between Ottavio Vitolo and Relmada Therapeutics, Inc (Filed With SEC on May 15, 2020)

Open Market Sale AgreementSM dated as of May 15, 2020 by and between Relmada Therapuetics, Inc. and Jefferies LLC (Filed With SEC on May 15, 2020)

Employment Agreement, dated March 7, 2020, by and between Thomas Wessel and Relmada Therapeutics, Inc (Filed With SEC on March 12, 2020)

Amendment No. 5 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on March 9, 2020)

Employment Agreement, dated January 9, 2020, by and between Maged Shenouda and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)

Employment Agreement, dated January 9, 2020, by and between Charles Ence and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)

Amended and Restated Employment Agreement, dated January 9, 2020, by and between Sergio Traversa and Relmada Therapeutics, Inc (Filed With SEC on January 10, 2020)

Director Agreement, effective December 19, 2019, by and between Eric Schmidt and Relmada Therapeutics, Inc (Filed With SEC on December 26, 2019)

Indemnity Agreement, effective December 19, 2019, by and between Eric Schmidt and Relmada Therapeutics, Inc (Filed With SEC on December 26, 2019)

Director Agreement, effective December 19, 2019, by and between John Glasspool and Relmada Therapeutics, Inc (Filed With SEC on December 26, 2019)

Indemnity Agreement, effective December 19, 2019, by and between John Glasspool and Relmada Therapeutics, Inc (Filed With SEC on December 26, 2019)

Underwriting Agreement, dated December 3, 2019, by and among Relmada Therapeutics, Inc. and Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters named... (Filed With SEC on December 6, 2019)

Amended and Restated Unit Purchase Agreement dated November 27, 2019, between Relmada Therapeutics, Inc., and certain accredited investors (Filed With SEC on December 3, 2019)

Amendment No.1 To License Agreement dated December 2, 2019, to the License Agreement dated January 16, 2018 between Relmada Therapeutics, Inc., and Dr. Charles E. Inturrisi and... (Filed With SEC on December 3, 2019)

Form of Share Purchase Agreement, dated September 23, 2019 and September 26, 2019, among Relmada Therapeutics, Inc. and certain accredited investors named therein (Filed With SEC on November 13, 2019)

Form of Registration Rights Agreement, dated September 23, 2019 and September 26, 2019, among Relmada Therapeutics, Inc. and certain accredited investors named therein (Filed With SEC on November 13, 2019)

Consulting Agreement, dated July 29, 2019, by and between Charles S. Ence and Relmada Therapeutics, Inc (Filed With SEC on July 29, 2019)

Indemnification Agreement, dated July 29, 2019, by and between Charles S. Ence and Relmada Therapeutics, Inc (Filed With SEC on July 29, 2019)

Confidential Information and Invention Assignment Agreement, dated July 29, 2019, by and between Charles S. Ence and Relmada Therapeutics, Inc (Filed With SEC on July 29, 2019)

Form of Warrant (Filed With SEC on May 15, 2019)

Amendment No. 4 to the Relmada Therapeutics, Inc. 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 15, 2019)

Form of Unit Purchase Agreement (Filed With SEC on May 15, 2019)

Form of Subscription Agreement (Filed With SEC on May 15, 2019)

Form of Registration Rights Agreement (Filed With SEC on May 15, 2019)

Lease Agreement, effective January 1, 2019, between Relmada Therapeutics, Inc. and 880 Third Avenue Tenant LLC (Filed With SEC on February 13, 2019)

Settlement Agreement, dated February 6, 2019, among Najib Babul, Laidlaw & Company (UK) Ltd., Sandesh Seth, and Sergio Traversa (Filed With SEC on February 13, 2019)

Consulting Agreement, effective March 25, 2019, between Relmada Therapeutics, Inc. and Najib Babul (Filed With SEC on February 13, 2019)

Form of 2018 Warrant (Filed With SEC on November 13, 2018)

Unit Purchase Agreement, dated as of October 12 and 18, 2018, and November 2, 2018 among Relmada Therapeutics, Inc. and certain accredited investors (Filed With SEC on November 13, 2018)

Subscription Agreement, dated as of October 12 and 18, 2018, and November 2, 2018 among Relmada Therapeutics, Inc. and certain accredited investors (Filed With SEC on November 13, 2018)

Registration Rights Agreement, dated as of October 12 and 18, 2018, and November 2, 2018 among Relmada Therapeutics, Inc. and certain accredited investors (Filed With SEC on November 13, 2018)

Offer Letter, Dated March 28, 2018, between Relmada Therapeutics, Inc. and Ottavio Vitolo (Filed With SEC on May 14, 2018)

Indemnification Agreement, dated April 2, 2018, between Relmada Therapeutics, Inc. and Ottavio Vitolo (Filed With SEC on May 14, 2018)

Third Amendment to the 2014 Stock Option and Equity Incentive Plan, as amended (Filed With SEC on May 14, 2018)

Form of Convertible Promissory Note (Filed With SEC on February 12, 2018)

Form of Warrant to Purchase Common Stock (Filed With SEC on February 12, 2018)

Form of Note and Warrant Purchase Agreement (Filed With SEC on February 12, 2018)

License Agreement, dated January 16, 2018, between Relmada Therapeutics, Inc. Dr. Charles E. Inturrisi and Dr. Paolo Manfredi (Filed With SEC on January 19, 2018)

Intellectual Property Assignment Agreement, dated January 16, 2018, between Relmada Therapeutics, Inc. Dr. Charles E. Inturrisi and Dr. Paolo Manfredi (Filed With SEC on January 19, 2018)

Consulting Agreement Termination Agreement, dated November 13, 2017, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on November 14, 2017)

Consulting Agreement, dated February 15, 2017, between Relmada Therapeutics, Inc. and MDB Consulting LLC (Filed With SEC on September 28, 2017)

Assignment and Consent Agreement, dated June 6, 2017, among 275 Madison Avenue RPW 1 LLC, 275 Madison Avenue RPW 2, LLC, Actinium Pharmaceuticals, Inc. and Relmada Therapeutics,... (Filed With SEC on September 28, 2017)

Lease Agreement, dated May 2, 2017, between Relmada Therapeutics, Inc. and Regus Management Group, LLC (Filed With SEC on September 28, 2017)

Amended and Restated License Agreement, dated June 8, 2017, between Actinium Pharmaceuticals, Inc. and Relmada Therapeutics, Inc (Filed With SEC on September 28, 2017)

Agreement, dated June 6, 2017, between Relmada Therapeutics, inc. and Sandesh Seth (Filed With SEC on September 28, 2017)

Consulting Agreement, dated June 12, 2017, between Relmada Therapeutics, Inc. and Maged Shenouda (Filed With SEC on September 28, 2017)

AMENDMENT NO. 2 TO RELMADA THERAPEUTICS, INC. 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on February 10, 2017)

AGREEMENT (Filed With SEC on September 9, 2016)

AMENDMENT TO OFFERLETTER (Filed With SEC on June 17, 2016)

(Signaturepage follows) (Filed With SEC on December 31, 2015)

RELMADA THERAPEUTICS, INC. 757 Third Avenue, Suite 2018 New York, NY 10017 (Filed With SEC on November 12, 2015)

INDEMNIFICATIONAGREEMENT (Filed With SEC on November 12, 2015)

RELMADA THERAPEUTICS, INC. 757 Third Avenue, Suite 2018 New York, NY 10017 (Filed With SEC on November 12, 2015)

INDEMNIFICATIONAGREEMENT (Filed With SEC on November 12, 2015)

RELMADATHERAPEUTICS, INC. FIRSTAMENDMENT TO THE 2014 STOCK OPTION AND EQUITY INCENTIVE PLAN (Filed With SEC on August 7, 2015)

FORMOF INDEMNIFICATIONAGREEMENT (Filed With SEC on August 7, 2015)

TERMINATIONAGREEMENT (Filed With SEC on August 7, 2015)

ADVISORY AND CONSULTING AGREEMENT (Filed With SEC on August 7, 2015)

RELMADATHERAPEUTICS, INC. 757Third Avenue, Suite 2018 NewYork, NY 10017 (Filed With SEC on July 16, 2015)

INDEMNIFICATIONAGREEMENT (Filed With SEC on July 16, 2015)

RelmadaTherapeutics, Inc. 2014STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION1. PURPOSE (Filed With SEC on December 9, 2014)

FORM OF A WARRANT EXHIBIT B-1 (Filed With SEC on June 16, 2014)

FORM OF B WARRANT EXHIBIT B-2 (Filed With SEC on June 16, 2014)

UNIT PURCHASE AGREEMENT BY AND AMONG CAMP NINE, INC. AND THE PURCHASERS PARTY HERETO June 10,2014 (Filed With SEC on June 16, 2014)

To subscribe for Units including Common Stock and Warrants to Purchase Shares of Common Stock in the private offering of CAMP NINE, INC. (Filed With SEC on June 16, 2014)

2014 UNIT INVESTOR RIGHTS AGREEMENT (Filed With SEC on June 16, 2014)

SHARE EXCHANGE AGREEMENT BY AND AMONG CAMP NINE, INC. AND RELMADA THERAPEUTICS, INC. AND THE SHAREHOLDERS OF RELMADA THERAPEUTICS, INC. Dated as of:May 20, 2014 TABLE OF CONTENTS (Filed With SEC on May 27, 2014)

Form of Warrant (Filed With SEC on May 27, 2014)

FORM OF A WARRANT (Filed With SEC on May 27, 2014)

FORM OF B WARRANT (Filed With SEC on May 27, 2014)

OPTION TO PURCHASE COMMON STOCK OF RELMADA THERAPEUTICS, INC. (Filed With SEC on May 27, 2014)

LOCK-UP LETTER AGREEMENT (Filed With SEC on May 27, 2014)

AGREEMENT AND PLAN OF MERGER among RELMADA THERAPEUTICS, INC. and MEDEOR, INC. dated as of December 31, 2013 AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 27, 2014)

NON-DISCLOSURE, ASSIGNMENT OF INVENTIONS, NON-SOLICITATION AND NON-COMPETE AGREEMENT (Filed With SEC on May 27, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on May 27, 2014)

RELMADA (Filed With SEC on May 27, 2014)

RELMADA Therapeutics (Filed With SEC on May 27, 2014)

COPY NON-DISCLOSURE, ASSIGNMENT OF INVENTIONS, NON-SOLICITATION AND NON-COMPETE AGREEMENT (Filed With SEC on May 27, 2014)

UNIT PURCHASE AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND THE PURCHASERS PARTY HERETO May __,2014 SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENT (Filed With SEC on May 27, 2014)

2014 UNIT INVESTOR RIGHTS AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND THE INVESTORS PARTY HERETO _____________ __, 2014 2014 UNIT INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 27, 2014)

To subscribe for Units including Common Stock and Warrants to Purchase Shares of Common Stock in the private offering of RELMADA THERAPEUTICS, INC. (Filed With SEC on May 27, 2014)

RELMADA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 27, 2014)

Relmada Therapeutics, Inc. 2012 STOCK OPTION AND EQUITY INCENTIVE PLAN SECTION 1. PURPOSE (Filed With SEC on May 27, 2014)

Certificate of Designation (Filed With SEC on May 19, 2014)

RELMADA THERAPEUTICS, INC. (101)